eMaxHealth A University of Pennsylvania study, for example, showed a twofold to threefold increased risk of bladder cancer among people who used pioglitazone for five years or longer when compared with patients who took another common medication ( sulfonylurea ) ... and more »
Diabetes In Control This prospective study sought to identify the association between long-term sulfonylurea use and incident cardiovascular disease in type 2 diabetes patients who lacked cardiovascular disease at baseline using the Nurses' Health Study cohort. 4,902 ...
Endocrinology Advisor “So, these are just some historical correlates making our observational finding plausible and possibly could add to considerations regarding sulfonylurea prescription in patients with angina,” Dr. McGuire told Endocrinology Advisor. He said different ...
Clinical Advisor The biguanide metformin, widely used in the treatment of type 2 diabetes, was associated with a 55% increased risk of low thyroid-stimulating hormone (TSH) levels in patients with hypothyroidism when compared with sulfonylurea use. The research ...
Medical Xpress The Federal Joint Committee (G-BA) specified different appropriate comparator therapies for the subindications, resulting in a total of five comparisons: empagliflozin as monotherapy versus a sulfonylurea (A), in combination with metformin versus ... and more »
The Pharmaceutical Journal Only 24.5% of patients on metformin needed a second glucose-lowering medication, compared with 37.1% given a sulfonylurea , 39.6% treated with a thiazolidinedione and 36.2% with a DPP-4 inhibitor. For the latter three drugs, metformin was the most ...
News-Medical.net The Federal Joint Committee (G-BA) specified different appropriate comparator therapies for the subindications, resulting in a total of five comparisons...
AJMC.com Managed Markets Network Study Design: Patients with T2DM who were treated with saxagliptin (N = 13,929), sulfonylurea (N = 117,756), or sitagliptin (N = 36,813) in 2010 or later were identified in a database of commercially insured beneficiaries. Patients were required to ...
6minutes Changes to PBS prescribing criteria make it available on streamlined authority as an add-on therapy for patients with type 2 diabetes who have, or have had, HbA1c measurement greater than 7% despite treatment with either metformin or a sulfonylurea .
Business Standard The results showed that relatively low concentrations of isoliquiritigenin were highly effective in inhibiting IL-1beta production compared with known NLRP3 inflammasome inhibitors, such as parthenolide and sulfonylurea drug glyburide. For animal ... and more »
